Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Goldberg

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastomaFariba Navid, Paul M Sondel, Raymond Barfield, et al.
The Lancet. Infectious Diseases|November 1, 2025
Safe delivery of intensive care for Marburg virus disease in RwandaEric Seruyange, Ernest Nahayo, François Xavier Uwimana, et al.
The New England Journal of Medicine|September 10, 2025
Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical ResponsesSabin Nsanzimana, Eric Remera, Menelas Nkeshimana, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastomaFariba Navid, Paul M Sondel, Raymond Barfield, et al.
The Lancet. Infectious Diseases|November 1, 2025
Safe delivery of intensive care for Marburg virus disease in RwandaEric Seruyange, Ernest Nahayo, François Xavier Uwimana, et al.
The New England Journal of Medicine|September 10, 2025
Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical ResponsesSabin Nsanzimana, Eric Remera, Menelas Nkeshimana, et al.
Pageof 3